National Institute of Cancerologia – Developmental Therapeutics Review – Q4 2010

Date: December 1, 2010
Pages: 23
Price:
US$ 500.00 US$ 450.00
Offer valid until December 31, 2014!
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: NE1919A33FDEN
Leaflet:

Download PDF Leaflet

National Institute of Cancerologia - Developmental Therapeutics Review - Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “National Institute of Cancerologia - Developmental Therapeutics Review - Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope
  • Review of therapeutics under development by National Institute of Cancerologia.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of National Institute of Cancerologia with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of National Institute of Cancerologia’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.

Reasons to buy
  • Review of therapeutics under development by National Institute of Cancerologia.
  • Overview of products under development across various therapy areas.
  • Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of National Institute of Cancerologia with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
  • Recent updates of National Institute of Cancerologia’s therapeutic products in the last quarter.
  • Latest news and deals relating to the products.
National Institute of Cancerologia Snapshot
Key Facts
National Institute of Cancerologia – Research and Development Overview
Key Therapeutic Areas
National Institute of Cancerologia – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
National Institute of Cancerologia – Pipeline Products Glance
National Institute of Cancerologia – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
National Institute of Cancerologia Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
National Institute of Cancerologia – Drug Profiles
ATRA + Paclitaxel + Cisplatin
Product Description
Mechanism of Action
R&D Progress
Hydralazine + Magnesium Valproate + Cisplatin + Topotecan
Product Description
Mechanism of Action
R&D Progress
Liposomal doxorubicin + Cisplatin
Product Description
Mechanism of Action
R&D Progress
Transdermal nitroglycerin
Product Description
Mechanism of Action
R&D Progress
National Institute of Cancerologia – Pipeline Analysis
National Institute of Cancerologia – Pipeline Products by Therapeutic Class
National Institute of Cancerologia Pipeline Products By Target
National Institute of Cancerologia – Pipeline Products by Route of Administration
National Institute of Cancerologia – Pipeline Products by Molecule Type
National Institute of Cancerologia – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 2

LIST OF TABLES

National Institute of Cancerologia – Pipeline by Therapy Area and Indication, 2010
National Institute of Cancerologia – Pipeline by Stage of Development, 2010
National Institute of Cancerologia – Monotherapy Products in Pipeline, 2010
National Institute of Cancerologia – Combination Treatment Modalities in Pipeline, 2010
National Institute of Cancerologia – Phase III, 2010
National Institute of Cancerologia - Phase II, 2010
National Institute of Cancerologia - Pipeline By Therapeutic Class, 2010
National Institute of Cancerologia - Pipeline By Target, 2010
National Institute of Cancerologia – Pipeline By Route of Administration, 2010
National Institute of Cancerologia – Pipeline By Molecule Type, 2010 20

LIST OF FIGURES

National Institute of Cancerologia – Pipeline by Therapy Area and Indication, 2010
National Institute of Cancerologia – Pipeline by Stage of Development, 2010
National Institute of Cancerologia – Monotherapy Products in Pipeline, 2010
National Institute of Cancerologia – Combination Treatment Modalities in Pipeline, 2010
National Institute of Cancerologia – Pipeline By Therapeutic Class, 2010
National Institute of Cancerologia - Pipeline By Target, 2010
National Institute of Cancerologia – Pipeline By Molecule Type, 2010 20

Ask Your Question

National Institute of Cancerologia – Developmental Therapeutics Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: